Verve Therapeutics, Inc.
VERVDelisted Jul 25, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001840574
Verve Therapeutics, Inc. was delisted on Jul 25, 2025; its insiders filed their last Form 4 on Jul 28, 2025; 176 institutions reported holding it in 13F filings for Q2 2025, worth $819.4M in total; no superinvestor held it.
Q1 2026 vs. Q4 2025
How the institutions holding Verve Therapeutics, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Q1 2026 | Change |
|---|---|---|---|
| Holders | 4 | 3 | −1 |
| Shares | 50.0K | 27.1K | −22.9K (−45.8%) |
| Value | $344.0K | $0 | −$344.0K (−100.0%) |
New holders (1)
Institutions that held Verve Therapeutics, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sofos Investments, Inc. | 1 | $0 | 0.00% |
Sold out (2)
Institutions that held Verve Therapeutics, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| DekaBank Deutsche Girozentrale | 24,000 | $344.0K |
| GAMMA Investing LLC | 257 | $0 |